Protalix BioTherapeutics, Inc. (PLX) was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 24.1% in the past one-month time frame.
The company has seen no estimate revisions over the past 7 days, and the Zacks Consensus Estimate is unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Protalix BioTherapeutics currently has a Zacks Rank #3 (Hold) with a positive Earnings ESP.
Some better-ranked drug manufacturers include Gilead Sciences Inc. (GILD), Cambrex Corporation (CBM) and China Biologic Products, Inc. (CBPO). All these stocks sport a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment